Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial metabolism in oral bacteria encompasses the biochemical processes by which oral microbial communities break down substrates (carbohydrates, proteins, lipids) to generate energy and metabolic by-products. These activities influence oral health and disease, impacting the local environment, pathogenicity, and microbiome composition. Key pathways include glycolysis, arginine deiminase system, urease activity, proteolysis, and mucin degradation. Metabolites such as organic acids, short-chain fatty acids, amines, and gases contribute to caries, periodontal disease, and halitosis. Modulation of bacterial metabolism is a therapeutic target for managing oral health.
Inhibition of bacterial metabolic pathways, disruption of biofilm formation, modulation of oral microbiome composition, enzymatic breakdown of bacterial products.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Metabolism (Oral Bacteria).